Patents by Inventor David K. Gong

David K. Gong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hemophilia Treatment by Inhalation of Coagulation Factors
    Publication number: 20100124536
    Abstract: Hemophilia treatment by the inhalation of coagulation factors. Dry powder Factor IX is aerosolized to a mass median aerodynamic diameter of 4 ?m or less, with at least 90% monomer content, at least 80% activity level, and 10% water or less. The aerosol is slowly, and deeply inhaled into the lung, and followed by a maximal exhale.
    Type: Application
    Filed: January 24, 2010
    Publication date: May 20, 2010
    Applicants: Wyeth, Novartis Pharma Ag
    Inventors: Robert G. Schaub, Nicholas W. Warne, Andrew J. Dorner, Chandra A. Webb, James C. Keith, David K. Gong, Jayne E. Hastedt
  • STORAGE STABLE POWDER COMPOSITIONS OF INTERLEUKIN-4 RECEPTOR
    Publication number: 20090035264
    Abstract: The present invention provides storage stable dry powder compositions of IL-4R. The powder compositions demonstrate superior chemical and physical stability over their solution counterparts, particularly upon storage under varying conditions of temperature and humidity. Moreover, the powders, as prepared, possess good aerosol properties, which are maintained upon storage.
    Type: Application
    Filed: October 6, 2008
    Publication date: February 5, 2009
    Applicant: Nektar Therapeutics
    Inventors: Jayne E. Hastedt, Kirsten M. Cabot, David K. Gong, Dennis M. Hester
  • Storage stable power compositions of interleukin-4 receptor
    Patent number: 7449201
    Abstract: The present invention provides storage stable dry powder compositions of IL-4R. The powder compositions demonstrate superior chemical and physical stability over their solution counterparts, particularly upon storage under varying conditions of temperature and humidity. Moreover, the powders, as prepared, possess good aerosol properties, which are maintained upon storage.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: November 11, 2008
    Assignee: Nektar Therapeutics
    Inventors: Jayne E. Hastedt, Kirsten M. Cabot, David K. Gong, Dennis M. Hester
  • Storage stable powder compositions of interleukin-4 receptor
    Patent number: 6896906
    Abstract: The present invention provides storage stable dry powder compositions of IL-4R. The powder compositions demonstrate superior chemical and physical stability over their solution counterparts, particularly upon storage under varying conditions of temperature and humidity. Moreover, the powders, as prepared, possess good aerosol properties, which are maintained upon storage.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: May 24, 2005
    Assignee: Nektar Therapeutics
    Inventors: Jayne E. Hastedt, Kirsten M. Cabot, David K. Gong, Dennis M. Hester
  • Storage stable powder compositions of interleukin-4 receptor
    Publication number: 20020176846
    Abstract: The present invention provides storage stable dry powder compositions of IL-4R. The powder compositions demonstrate superior chemical and physical stability over their solution counterparts, particularly upon storage under varying conditions of temperature and humidity. Moreover, the powders, as prepared, possess good aerosol properties, which are maintained upon storage.
    Type: Application
    Filed: December 21, 2001
    Publication date: November 28, 2002
    Inventors: Jayne E. Hastedt, Kirsten M. Cabot, David K. Gong, Dennis M. Hester